BALYASNY ASSET MANAGEMENT L.P. – Sarepta Therapeutics, Inc. Transaction History
BALYASNY ASSET MANAGEMENT L.P. portfolio value:
$0
portfolio value
Sarepta Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | put | Increase | +36.15% | 100.8K shares | 21.06M | $110.54 | 379.6K |
| Q3 2022 | call | Decrease | -100.00% | -92.7K shares | -6.94M | $110.54 | 0 |
| Q3 2022 | share | Increase | +2342.98% | 353.81K shares | 39.64M | $110.54 | 368.91K |
| Q2 2022 | call | Increase | 0.00% | 92.7K shares | 6.94M | $74.96 | 92.7K |
| Q2 2022 | share | Decrease | -92.93% | -198.53K shares | -15.55M | $74.96 | 15.10K |
| Q2 2022 | put | Increase | +67.85% | 112.7K shares | 7.92M | $74.96 | 278.8K |
| Q1 2022 | share | Increase | +101.68% | 107.70K shares | 7.15M | $78.12 | 213.63K |
| Q1 2022 | put | Increase | +277.50% | 122.1K shares | 9.01M | $78.12 | 166.1K |
| Q4 2021 | share | Decrease | -56.45% | -137.30K shares | -12.95M | $90.59 | 105.92K |
| Q4 2021 | put | Decrease | -29.03% | -18K shares | -1.77M | $90.59 | 44K |
| Q4 2021 | call | Decrease | -100.00% | -78K shares | -7.21M | $90.59 | 0 |
| Q3 2021 | call | Increase | 0.00% | 78K shares | 7.21M | $92.48 | 78K |
| Q3 2021 | share | Increase | +49.79% | 80.84K shares | 9.87M | $92.48 | 243.23K |
| Q3 2021 | put | Increase | 0.00% | 62K shares | 5.73M | $92.48 | 62K |
| Q2 2021 | call | Decrease | -100.00% | -221K shares | -16.47M | $77.74 | 0 |
| Q2 2021 | share | Increase | +328.39% | 124.48K shares | 9.79M | $77.74 | 162.38K |
| Q1 2021 | call | Increase | +60.73% | 83.5K shares | -6.97M | $74.53 | 221K |
| Q1 2021 | share | Decrease | -56.73% | -49.70K shares | -12.11M | $74.53 | 37.90K |
| Q4 2020 | call | Increase | 0.00% | 137.5K shares | 23.44M | $170.49 | 137.5K |
| Q4 2020 | share | Increase | 0.00% | 87.60K shares | 14.93M | $170.49 | 87.60K |
| Q3 2019 | call | Decrease | -100.00% | -110K shares | -14.28M | $75.32 | 0 |
| Q3 2019 | share | Decrease | -100.00% | -144.25K shares | -21.92M | $75.32 | 0 |
| Q2 2019 | call | Increase | +26.44% | 23K shares | 3.91M | $151.95 | 110K |
| Q2 2019 | share | Decrease | -9.79% | -15.64K shares | 2.86M | $151.95 | 144.25K |
| Q1 2019 | call | Increase | +210.71% | 59K shares | 7.31M | $119.19 | 87K |
| Q1 2019 | share | Increase | +51.37% | 54.26K shares | 7.53M | $119.19 | 159.90K |
| Q4 2018 | call | Increase | 0.00% | 28K shares | 3.05M | $109.13 | 28K |
| Q4 2018 | share | Increase | +110.54% | 55.46K shares | 3.42M | $109.13 | 105.63K |
| Q3 2018 | call | Decrease | -100.00% | -113.7K shares | -15.02M | $161.51 | 0 |
| Q3 2018 | share | Decrease | -71.76% | -127.5K shares | -15.38M | $161.51 | 50.17K |
| Q2 2018 | call | Decrease | -38.54% | -71.3K shares | 1.32M | $132.18 | 113.7K |
| Q2 2018 | share | Decrease | -57.71% | -242.44K shares | -7.64M | $132.18 | 177.67K |
| Q1 2018 | share | Increase | +246.65% | 298.92K shares | 24.38M | $74.09 | 420.12K |
| Q1 2018 | call | Increase | 0.00% | 185K shares | 13.70M | $74.09 | 185K |
| Q4 2017 | share | Increase | +16.77% | 17.40K shares | 2.03M | $55.64 | 121.19K |
| Q3 2017 | share | Decrease | -30.78% | -46.14K shares | -346K | $45.36 | 103.78K |
| Q2 2017 | share | Decrease | -65.87% | -289.31K shares | -7.94M | $33.71 | 149.93K |
| Q1 2017 | call | Decrease | -100.00% | -300K shares | -8.22M | $29.6 | 0 |
| Q1 2017 | share | Increase | +139.18% | 255.60K shares | 7.96M | $29.6 | 439.24K |
| Q4 2016 | call | Increase | 0.00% | 300K shares | 8.22M | $27.43 | 300K |
| Q4 2016 | share | Increase | +58.49% | 67.77K shares | -2.07M | $27.43 | 183.64K |
| Q3 2016 | share | Increase | 0.00% | 115.86K shares | 7.11M | $61.41 | 115.86K |